International consensus on (ICON) pediatric asthma.

International consensus on (ICON) pediatric asthma.
复制标题

DOI:
10.1111/j.1398-9995.2012.02865.x
复制
发表时间:
2012-08
期刊:
影响因子:
12.4
通讯作者:
Zeiger RS
Zeiger RS
中科院分区:
医学1区
文献类型:
--
作者:
Papadopoulos NG;Arakawa H;Carlsen KH;Custovic A;Gern J;Lemanske R;Le Souef P;Mäkelä M;Roberts G;Wong G;Zar H;Akdis CA;Bacharier LB;Baraldi E;van Bever HP;de Blic J;Boner A;Burks W;Casale TB;Castro-Rodriguez JA;Chen YZ;El-Gamal YM;Everard ML;Frischer T;Geller M;Gereda J;Goh DY;Guilbert TW;Hedlin G;Heymann PW;Hong SJ;Hossny EM;Huang JL;Jackson DJ;de Jongste JC;Kalayci O;Aït-Khaled N;Kling S;Kuna P;Lau S;Ledford DK;Lee SI;Liu AH;Lockey RF;Lødrup-Carlsen K;Lötvall J;Morikawa A;Nieto A;Paramesh H;Pawankar R;Pohunek P;Pongracic J;Price D;Robertson C;Rosario N;Rossenwasser LJ;Sly PD;Stein R;Stick S;Szefler S;Taussig LM;Valovirta E;Vichyanond P;Wallace D;Weinberg E;Wennergren G;Wildhaber J;Zeiger RS

文献摘要

参考文献

被引文献

相似文献

哮喘是全世界儿童时期最常见的慢性下呼吸道疾病。有一些指南和/或共识文件可以支持小儿哮喘的医疗决策。尽管毫无疑问,使用通用的系统管理方法可以大大改善结果,但这些方法的传播和实施仍然是重大挑战。因此,最近由 EAACI、AAAAI、ACAAI 和 WAO 成立的哮喘、过敏和免疫学国际合作组织 (iCAALL) 决定提出一项关于 (ICON) 小儿哮喘的国际共识。本文件的目的是强调许多现有指南的共同关键信息,同时严格审查和评论任何差异,从而提供简明的参考。小儿哮喘管理原则已被普遍接受。总体而言,治疗目标是控制疾病。为了实现这一目标,应教育患者及其父母与医疗保健专业人员合作,以最佳方式控制疾病。识别和避免触发因素也非常重要。应定期进行评估和监测,以重新评估和微调治疗。药物治疗是治疗的基石。在大多数情况下,药物的最佳使用可以帮助患者控制症状并降低未来发病的风险。急性发作的管理是一个主要考虑因素,独立于长期治疗。有一种趋势是考虑表型特异性的治疗选择;然而这一目标尚未实现。
Asthma is the most common chronic lower respiratory disease in childhood throughout the world. Several guidelines and/or consensus documents are available to support medical decisions on pediatric asthma. Although there is no doubt that the use of common systematic approaches for management can considerably improve outcomes, dissemination and implementation of these are still major challenges. Consequently, the International Collaboration in Asthma, Allergy and Immunology (iCAALL), recently formed by the EAACI, AAAAI, ACAAI and WAO, has decided to propose an International Consensus on (ICON) Pediatric Asthma. The purpose of this document is to highlight the key messages that are common to many of the existing guidelines, while critically reviewing and commenting on any differences, thus providing a concise reference. The principles of pediatric asthma management are generally accepted. Overall, the treatment goal is disease control. In order to achieve this, patients and their parents should be educated to optimally manage the disease, in collaboration with health care professionals. Identification and avoidance of triggers is also of significant importance. Assessment and monitoring should be performed regularly to re-evaluate and fine-tune treatment. Pharmacotherapy is the cornerstone of treatment. The optimal use of medication can, in most cases, help patients control symptoms and reduce the risk for future morbidity. The management of exacerbations is a major consideration, independent from chronic treatment. There is a trend towards considering phenotype specific treatment choices; however this goal has not yet been achieved.
DOI: 10.1016/j.jaci.2004.02.006
发表时间: 2004-06-01
影响因子: 14.2
作者:
Bernstein, DI;Wanner, M;Liss, GM
通讯作者: Liss, GM
DOI: 10.1164/rccm.200308-1178oc
发表时间: 2004-08-15
影响因子: 24.7
作者:
Bacharier, LB;Strunk, RC;Sorkness, CA
通讯作者: Sorkness, CA
DOI: 10.1111/j.1398-9995.2012.02786.x
发表时间: 2012-04-01
期刊: ALLERGY
影响因子: 12.4
作者:
Ballardini, N.;Kull, I.;Wickman, M.
通讯作者: Wickman, M.
DOI: 10.1067/mai.2001.114657
发表时间: 2001-03-01
影响因子: 14.2
作者:
Busse, W;Raphael, GD;Rickard, K
通讯作者: Rickard, K
DOI: 10.1111/j.1398-9995.2010.02405.x
发表时间: 2010-11-01
期刊: ALLERGY
影响因子: 12.4
作者:
Andrade, W. C. C.;Camargos, P.;Bousquet, J.
通讯作者: Bousquet, J.